Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LAURUS LABS Plunges 4%; BSE HEALTHCARE Index Down 1.2%
Wed, 18 Sep 13:9

LAURUS LABS  Plunges 4%; BSE HEALTHCARE Index Down 1.2%Image source: ipopba/www.istockphoto.com

LAURUS LABS share price has plunged 4% and is presently trading at Rs 482.9.

Meanwhile, the BSE HEALTHCARE index is at 43,772.1 (down 1.2%).

Among the top losers in the BSE HEALTHCARE index today are Abbott India (down 3.9%) and KIMS (down 3.6%).

POLY MEDICURE (up 3.1%) and GSK Pharma (up 0.7%) are among the top gainers today.

Over the last one year, LAURUS LABS has moved up from Rs 393.6 to Rs 482.9, registering a gain of Rs 89.3 (up 22.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,508.7 to 43,772.1, registering a gain of 53.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 176.0%), SUVEN PHARMACEUTICALS (up 106.2%) and Lupin (up 96.0%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 83,121.3 (up 0.1%).

The top gainers among the BSE Sensex today are Bajaj Finance (up 3.6%) and Bajaj Finserv (up 2.2%). The most traded stocks in the BSE Sensex are SBI and Tata Steel.

In the meantime, NSE Nifty is at 25,386.7 (down 0.1%). TCS and HCl Tech. are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 67,596.8 to 83,121.3, registering a gain of 15,524.4 points (up 23.0%).

LAURUS LABS Financial Update...

LAURUS LABS net profit fell 57.0% YoY to Rs 122 million for the quarter ended June 2024, compared to a profit of Rs 284 million a year ago. Net sales rose 1.1% to Rs 11,949 million during the period as against Rs 11,818 million in April-June 2023.

For the year ended March 2024, LAURUS LABS reported 78.9% decrease in net profit to Rs 1,682 million compared to net profit of Rs 7,966 million during FY23. Revenue of the company fell 16.6% to Rs 50,408 million during FY24.

The current Price to earnings ratio of LAURUS LABS , based on rolling 12 month earnings, stands at 171.3.


Equitymaster requests your view! Post a comment on "LAURUS LABS Plunges 4%; BSE HEALTHCARE Index Down 1.2%". Click here!